Raynaud-Phänomen in der Dermatologie-Reference-Cited by-同舟云学术

Raynaud-Phänomen in der Dermatologie

Published:2006-10 Issue:10 Volume:57 Page:927-942
ISSN:0017-8470
Container-title:Der Hautarzt
language:de
Short-container-title:Hautarzt

Author:

Sunderkötter C.,Riemekasten G.

Publisher

Springer Science and Business Media LLC

Subject

Dermatology

Link

http://link.springer.com/content/pdf/10.1007/s00105-006-1218-4.pdf

Reference64 articles.

1. Andersen GN, Mincheva-Nilsson L, Kazzam E et al. (2002) Assessment of vascular function in systemic sclerosis: indications of the development of nitrate tolerance as a result of enhanced endothelial nitric oxide production. Arthritis Rheum 46: 1324–1332

2. Bali G, Aberer E (2003) Iloprost therapy in systemic sclerosis. Hautarzt 54: 845–851

3. Bartolone S, Trifiletti A, De Nuzzo G et al. (1999) Efficacy evaluation of prostaglandin E1 against placebo in patients with progressive systemic sclerosis and significant Raynaud’s phenomenon. Minerva Cardioangiol 47: 137–143

4. Beckett VL, Conn DL, Fuster V et al. (1984) Trial of platelet-inhibiting drug in scleroderma. Double-blind study with dipyridamole and aspirin. Arthritis Rheum 27: 1137–1143

5. Bettoni L, Geri A, Airo P et al. (2002) Systemic sclerosis therapy with iloprost: a prospective observational study of 30 patients treated for a median of 3 years. Clin Rheumatol 21: 244–250

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemische Sklerose;Aktuelle Rheumatologie;2017-08

2. Systemische Sklerodermie;Humanmedizin kompakt;2013-06-27

3. Systemische Sklerodermie;Der Hautarzt;2013-04

4. Systemische Sklerodermie;Fortschritte der praktischen Dermatologie und Venerologie 2012;2013

5. Das Deutsche Netzwerk für Systemische Sklerodermie (DNSS);Der Hautarzt;2012-04